ImmunoScape
  • About Us
  • Our Science
  • Our Pipeline
  • News & resources
    • News
    • Publications
  • Partnering
  • Contact us
News
Nov 13, 2025

Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments

“Seed-and-Boost” Approach with Breakthrough Potential, Poised to Transform the Cancer Immunotherapy Landscape SINGAPORE -- ImmunoScape Pte. Ltd., an A*STAR spin out...

$
Nov 4, 2025

Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors

Exclusive collaboration and license agreement focuses on advancing novel, T cell therapy “Seed-and-Boost” approach exploiting the mechanism of the CUE-100 series of...

$
immuno scape footer logo
  • Follow
  • Follow
  • Follow
ImmunoScape, Global Headquarters:

ImmunoScape Pte Ltd
1 Scotts Road #24-10
Singapore 228208

Copyright © 2025 ImmunoScape.

Privacy Policy